(PharmaNewsWire.Com, December 15, 2017 ) The Latin America Contrast Injector Market was worth USD 67.28 million in 2016 and is projected to be growing at a CAGR of 6.8%, to touch USD 93.48 million by 2021. Contrast Injectors, also known as pressure/power injectors are widely used in the techniques of magnetic resonance imaging (MRI), computed tomography and interventional radiology. Contrast Injectors have the capability to deliver precise amounts of contrast agents at required flow rates which helps substantively in medical imaging procedures.
The main task of a Contrast Injector is to inject contrast media into the blood stream. Present day injectors offer substantial benefits such as the integration of IT and the utility of computer controlled system which deliver total control over the injection parameters.
The growth of the Latin America Contrast Injector Market is driven by factors such as the increasing approvals for contrast media use, cost savings offered by automated injectors and the increasing number of public and private diagnostic centres. Furthermore, plans by companies to expand into the untapped markets of the region are expected to boost market growth. The factors inhibiting market growth in the region include the side effects and side reactions associated with the use of contrast media.
The Latin America Contrast Injector Market is segmented on the basis of Product, Application and Geography. Based on the Product, the Contrast Injector market is allocated into injector systems, consumables, and accessories. The injector systems segment is further distributed into CT injector systems, MRI injector systems, and angiography injector systems. The consumables segment is further segmented into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. On the basis of application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology.
Latin America market region includes countries such as Brazil, Mexico, Argentina, and remaining countries of South America. Brazil is one of the largest markets in this region followed by Mexico, Argentina, and Columbia. There is potential for market growth in the future due to increasing approvals for the use of contrast media and the rising infrastructural investments for private and public diagnostic centres.
The significant players in the Latin America Contrast Injector Market are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
Market Segmentation
1)Product Introduction Injector Systems CT Injector Systems MRI Injector Systems Angiography Injector Systems
Scope of the report: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
